Birchview Capital’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $358K | Hold |
|
|||||
|
2025
Q1 | $300K | Hold |
|
|||||
|
2024
Q4 | $301K | Hold |
|
|||||
|
2024
Q3 | $304K | Hold |
|
|||||
|
2024
Q2 | $247K | Buy |
|
|||||
|
2024
Q1 | $102K | Hold |
|
|||||
|
2023
Q4 | $120K | Hold |
|
|||||
|
2023
Q3 | $142K | Hold |
|
|||||
|
2023
Q2 | $141K | Hold |
|
|||||
|
2023
Q1 | $167K | Hold |
|
|||||
|
2022
Q4 | $230K | Hold |
|
|||||
|
2022
Q3 | $252K | Hold |
|
|||||
|
2022
Q2 | $212K | Hold |
|
|||||
|
2022
Q1 | $325K | Hold |
|
|||||
|
2021
Q4 | $277K | Hold |
|
|||||
|
2021
Q3 | $287K | Hold |
|
|||||
|
2021
Q2 | $316K | Hold |
|
|||||
|
2021
Q1 | $203K | Hold |
|
|||||
|
2020
Q4 | $149K | Hold |
|
|||||
|
2020
Q3 | $69K | Hold |
|
|||||
|
2020
Q2 | $95K | Hold |
|
|||||
|
2020
Q1 | $40K | Hold |
|
|||||
|
2019
Q4 | $69K | Hold |
|
|||||
|
2019
Q3 | $57K | Hold |
|
|||||
|
2019
Q2 | $76K | Buy |
|